维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="LEWIECKI E M"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Clinical use of serum and urine bone markers in the management of osteoporosis显示文摘	SRIVASTAVA A K VLIET E L LEWIECKI E M	2005	Curr Med Res Opin2005，21，：	1
2	Emerging drugs for postmenopausal osteoporosis显示文摘	Lewiecki E M	2009	Expert Opin Emerging Drugs2009，14，1：	1
3	Preci- sion assessment and radiation safety for dual-energy X-ray absorptiometry : Position paper of the International Society for Clinical Densitometry 显示文摘	BAIM S WILSON C R LEWIECKI E M	2008	Journal of Clinical Densi- tometry2008，8，4：	1
4	Sclerostin inhibition:a novel therapeutic approach in the treatment of osteoporosis显示文摘	SHAH A D SHOBACK D LEWIECKI E M	2015	International Journal of Women′s Health2015，7，：	1
5	Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases显示文摘	LEWIECKI E M	2014	Therapeutic Advances in Musculoskeletal Disease2014，6，2：	1
6	Intravenous zoledronic acid for thetreatment of osteoporosis:The evidence of its therapeuticeffect显示文摘	LEWIECKI E M	2010	Core Evid2010，15，4：	1
7	Official positions of the International Society for Clinical Densitometry 显示文摘	Leib E Lewiecki M Binkley N	2004	South Med J2004，97，10：	1
8	AMG 162 Administered every 6 months causes rapid and sustained decreases in bone turnover in postmenopausal women with low bone mineral density (BMD) 显示文摘	Cohen S McClung M Lewiecki E	2005	Arthritis Rheum2005，1，：	1
9	Intravenous zoledronic acid for the treatment ofosteoporo- sis显示文摘	Lewiecki E M	2008	Curt Osteoporos Rep2008，6，1：	1
10	Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk显示文摘	Lewiecki E M Miller P D	2013	J Clin Densitom2013，16，1：	1
11	Osteoporosis update from the 2010 santa fe bone symposium显示文摘	Lewiecki E M Bilezikian J P Khosla S	2011	J Clin Densitom2011，14，1：	1
12	New targets for intervention in the treatment of postmenopausal osteoporosis 显示文摘	Lewiecki E M	2011	Nat Rev Rheumatol2011，7，11：	1
13	Prevention and treatment of postmenopausal osteoporosis显示文摘	Lewiecki E M	2008	Obstet Gyneeol Clin North Am2008，35，2：	1
14	Vertebroplasty and kyphoplasty in 2001 显示文摘		2001	J Clinical Densitometry2001，4，：	1
15	Managing osteoporosis: Challenges and strategies 显示文摘	Lewiecki E M	2009	Cleveland Clinic Journal of Medicine2009，76，：	1
16	RANK ligand inhibition with denosumab for the management of osteoporosis 显示文摘	Lewiecki E M	2006	Expert Opin Biol Ther2006，6，10：	1
17	Intravenous zoledronie acid for the treatment of osteoporosis显示文摘	Lewiecki E M		0，，01：	1
18	Precision as- sessment and radiation safety for dual-energy x-ray ab- sorptiometry:position paper of the International Society for Clinical Densitometry显示文摘	Baim S Wilson C R Lewiecki E M	2005	J Clin Densitom2005，8，4：	1
19	Official positions of the international society for clinical densitometry显示文摘	Lewiecki E Watts N McClung M	2004	J Clin Endocrinol Metab2004，89，8：	1
20	Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate10 mg:a multicenter,randomized,open-label,crossover study显示文摘	Simon J A Lewiecki E M Smith M E	2002	Clin Ther2002，24，11：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示